indazoles has been researched along with Shock, Septic in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Brzózka, K; Dreas, A; Fabritius, CH; Gabor-Worwa, E; Gołas, A; Kucwaj-Brysz, K; Kulesza, U; Majewska, E; Masiejczyk, M; Michalik, K; Mikula, M; Milik, M; Ostrowski, J; Pyśniak, K; Pyziak, K; Rzymski, T; Sandowska-Markiewicz, Z; Wincza, E; Wójcik-Trechcińska, U | 1 |
| Qian, LB; Xia, ML; Xia, Q; Xu, C; Zhou, XM | 1 |
| Bruce, IC; Wang, H; Xia, Q; Xu, C; Yi, C | 1 |
| Fong, TH; Hsiao, G; Huang, HY; Lin, CH; Shen, MY; Sheu, JR; Teng, CM | 1 |
| Chang, JH; Chang, YL; Cheng, FC; Guh, JH; Kuo, SC; Lee, FY; Pan, SL; Peng, CY; Teng, CM | 1 |
| Falk, A; Larsson, A; Risberg, B; Schützer, KM | 1 |
6 other study(ies) available for indazoles and Shock, Septic
| Article | Year |
|---|---|
Discovery of indazole-pyridinone derivatives as a novel class of potent and selective MNK1/2 kinase inhibitors that protecting against endotoxin-induced septic shock.
Topics: Amino Acid Sequence; Animals; Cytokines; Dose-Response Relationship, Drug; Drug Discovery; Endotoxins; Eukaryotic Initiation Factor-4E; Humans; Immunologic Factors; Indazoles; Intracellular Signaling Peptides and Proteins; Mice; Molecular Docking Simulation; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Pyridones; Shock, Septic; Signal Transduction; Structure-Activity Relationship | 2021 |
[Effect of nitric oxide synthase inhibitors on the changes of hemodynamic parameters and aortic tension induced by septic shock in rats].
Topics: Animals; Aorta, Thoracic; Enzyme Inhibitors; Hemodynamics; Indazoles; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Random Allocation; Rats; Rats, Sprague-Dawley; Shock, Septic | 2008 |
Mitochondrial nitric oxide synthase participates in septic shock myocardial depression by nitric oxide overproduction and mitochondrial permeability transition pore opening.
Topics: Animals; Disease Models, Animal; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Indazoles; Male; Mitochondria, Heart; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Mitochondrial Proteins; Muscle Proteins; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Shock, Septic | 2012 |
Inhibitory mechanisms of YC-1 and PMC in the induction of iNOS expression by lipoteichoic acid in RAW 264.7 macrophages.
Topics: Animals; Chromans; Drug Interactions; Enzyme Activation; Gene Expression; Indazoles; Lipopolysaccharides; Macrophages; Male; Mice; Mitogen-Activated Protein Kinases; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrites; Rats; Rats, Wistar; RNA, Messenger; Shock, Septic; Teichoic Acids | 2004 |
A potential role of YC-1 on the inhibition of cytokine release in peripheral blood mononuclear leukocytes and endotoxemic mouse models.
Topics: Animals; Blotting, Western; Cyclic GMP; Cytokines; Disease Models, Animal; DNA; Endotoxemia; Humans; Immunohistochemistry; Indazoles; Leukocytes; Leukocytes, Mononuclear; Lipopolysaccharides; Lung; Male; Mice; Mice, Inbred ICR; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Platelet Aggregation Inhibitors; Rats; Rats, Wistar; Shock, Septic; Time Factors; Up-Regulation | 2005 |
Leukotriene receptor antagonism prevents lung protein leakage and hypoxaemia in a septic cat model.
Topics: Analysis of Variance; Animals; Capillary Permeability; Cats; Diethylcarbamazine; Disease Models, Animal; Hypoxia; Indazoles; Leukotriene Antagonists; Leukotrienes; Lung; Organ Size; Shock, Septic | 1994 |